October 24th, 2026AAO 2026: GLP-1RA initiation not linked to anti-VEGF burden in DMEIRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA.Read more
October 22nd, 2026Murtaza K. Adam, MD, on pearls for the Yamane scleral-fixated IOL techniqueMurtaza K. Adam, MD, shares pearls on haptic docking, patient selection, and preventing complications with the Yamane technique.Read more
October 19th, 2026AAO 2026: Rethinking dry eye as a spectrum of ocular painAnat Galor, MD, MSPH, discusses subtyping dry eye, emerging diagnostic tools, and when to consider oral neuromodulation.Read more
October 18th, 2026AAO 2026: Preventing complications in uveitic cataract surgeryAt AAO 2026, Anjum F. Koreishi, MD, shared how to prevent complications after cataract surgery in patients with uveitis.Read more
October 17th, 2026AAO 2026: Setting realistic expectations with refractive IOLsDavid F. Chang, MD, shares how to set realistic refractive IOL expectations and streamline patient counseling.Read more
October 17th, 2026AAO 2026: Comprehensive ophthalmologists are the uveitis front lineTimothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.Read more
October 16th, 2026OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplantOT Roundup covers the optogenetics Nobel Prize, remigromig in DME with Veeral Sheth, MD, Stargardt disease and a total human eye transplant.Read more
October 15th, 2026AAO 2026: The optic nerve is the barrier to sight in eye transplantVaidehi Dedania, MD, discussed surgical advances, candidates, and how far whole eye transplant is from clinical use.Read more